Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Accelerated Stability Testing of Gels – V 2.0

Posted on By

Gel Manufacturing: SOP for Accelerated Stability Testing of Gels – V 2.0

Standard Operating Procedure for Conducting Accelerated Stability Testing of Gel Products


Department Gel Manufacturing
SOP No. SOP/GM/102/2025
Supersedes SOP/GM/102/2022
Page No. Page 1 of 11
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

To describe the procedure for performing accelerated stability testing on gel-based pharmaceutical products in compliance with ICH Q1A(R2) guidelines to evaluate their shelf life and stability under stress conditions.

2. Scope

This SOP is applicable to all gel products manufactured in the Gel

Manufacturing department that require accelerated stability studies prior to commercial release or regulatory submissions.

3. Responsibilities

  • Quality Control (QC): Responsible for conducting the stability tests and maintaining documentation.
  • Stability Coordinator: Ensures timely execution, monitoring, and documentation of the study.
  • Quality Assurance (QA): Responsible for review and approval of study protocols and results.
See also  Gel Manufacturing: SOP for Process Validation of Gel Manufacturing Batches - V 2.0

4. Accountability

The Head – Quality Assurance is accountable for ensuring adherence to regulatory standards and maintaining data integrity of stability testing.

5. Procedure

5.1 Preparation of Stability Protocol

  1. Draft the stability study protocol that includes:
    • Product name, batch number, and storage conditions
    • Testing intervals (0, 1, 2, 3, and 6 months)
    • Test parameters: assay, pH, viscosity, microbial load, appearance, and others
  2. Get the protocol approved by QA prior to study initiation.

5.2 Sample Collection and Labeling

  1. Collect adequate number of final product containers from each batch.
  2. Label each sample with stability ID, batch number, storage condition, and time points.
  3. Record the details in the Accelerated Stability Sample Logbook (Annexure-1).

5.3 Storage Conditions

  1. Store samples in stability chambers at:
    • 40°C ± 2°C / 75% RH ± 5% RH (ICH recommended)
  2. Chambers must be qualified and monitored using data loggers.

5.4 Stability Testing Schedule

  1. Perform tests at defined intervals (0, 1, 2, 3, and 6 months).
  2. Ensure that all analytical methods are validated for accuracy and precision.
  3. Record all results in the Accelerated Stability Data Sheet (Annexure-2).
See also  Gel Manufacturing: SOP for Line Clearance Before Gel Production - V 2.0

5.5 Data Analysis and Reporting

  1. QC compiles raw data, chromatograms, and observations.
  2. QA verifies the integrity and accuracy of the results.
  3. Use trend charts and statistical tools to assess degradation or anomalies.

5.6 Final Report

  1. Prepare a final report using the template (Annexure-3).
  2. Include conclusions, graphical analysis, and justification for product shelf life.
  3. Submit the report to QA for final approval.

6. Abbreviations

  • QC: Quality Control
  • QA: Quality Assurance
  • RH: Relative Humidity
  • ICH: International Council for Harmonisation

7. Documents

  1. Accelerated Stability Protocol – Annexure-1
  2. Accelerated Stability Data Sheet – Annexure-2
  3. Accelerated Stability Final Report – Annexure-3

8. References

  • ICH Q1A(R2) – Stability Testing of New Drug Substances and Products
  • WHO Stability Guidelines
  • Schedule M – Good Manufacturing Practices
See also  Gel Manufacturing: SOP for Ensuring Uniform Distribution of Actives in Gels - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Accelerated Stability Sample Logbook

Date Batch No. Sample Code Storage Condition Time Points Initials
40°C/75%RH 0,1,2,3,6 months

Annexure-2: Accelerated Stability Data Sheet


Time Point Appearance Assay pH Viscosity Microbial Load Remarks
0 Month
1 Month

Annexure-3: Accelerated Stability Final Report Template

Product Name: ___________
Batch No.: ___________
Storage Condition: 40°C ± 2°C / 75% RH ± 5% RH
Duration: 6 Months
Summary: Include graphical plots, test results, out-of-spec data, conclusions on stability.

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/06/2022 1.0 Initial SOP release New document QA Head
02/06/2025 2.0 Updated annexures, improved reporting structure Annual review QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Analytical Method Development: SOP for Headspace GC Method Development – V 2.0
Next Post: Biosimilars: SOP for Water for Injection (WFI) Systems Usage – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version